tiprankstipranks
Treatment.com International (DE:939)
FRANKFURT:939

Treatment.com International (939) Stock Price & Analysis

0 Followers

939 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.04 - €0.78
Previous Close€0.44
Volume2.00K
Average Volume (3M)2.71K
Market Cap
€3.12M
Enterprise Value€3.59M
Total Cash (Recent Filing)C$474.00
Total Debt (Recent Filing)C$686.01K
Price to Earnings (P/E)N/A
Beta-3.20
May 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding37,105,115
10 Day Avg. Volume3,400
30 Day Avg. Volume2,710
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-9.33
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-129.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

939 FAQ

What was Treatment.com International’s price range in the past 12 months?
Treatment.com International lowest stock price was €0.04 and its highest was €0.78 in the past 12 months.
    What is Treatment.com International’s market cap?
    Currently, no data Available
    When is Treatment.com International’s upcoming earnings report date?
    Treatment.com International’s upcoming earnings report date is May 28, 2024 which is in 23 days.
      How were Treatment.com International’s earnings last quarter?
      Currently, no data Available
      Is Treatment.com International overvalued?
      According to Wall Street analysts Treatment.com International’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Treatment.com International pay dividends?
        Treatment.com International does not currently pay dividends.
        What is Treatment.com International’s EPS estimate?
        Treatment.com International’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Treatment.com International have?
        Currently, no data Available
        What happened to Treatment.com International’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Treatment.com International?
        Currently, no hedge funds are holding shares in DE:939
        ---

        Company Description

        Treatment.com International

        Treatment.com International Inc operates in the mobile health, digital health, telemedicine, and artificial intelligence segments of the global health industry. Its first commercial mobile application is an internally-developed medical intelligence platform, code-named as MERLIN. Multiple pre-production versions of MERLIN are running in multiple Google Cloud Datacenters in the U.S., Canada, and Singapore. The scale and scope of Google Cloud Services provide the company with the data centers and software services needed to provide its diagnostic and treatment services to a global customer base, in multiple languages.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Teladoc
        T2 Biosystems
        Zoetis
        Idexx Laboratories
        Treatment.com International
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis